Physician

Alan J Klukowicz, MD

According to 2025 Medicare claims, Alan Klukowicz, MD (NPI: 1912959685) practices pulmonary disease in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. This provider's primary affiliated billing organization is PULMONARY & CRITICAL CARE ASSOCIATES (NPI: 1467536623; TIN: 223045717) and primary practice location at 07102-2011.

Klukowicz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 16 traditional Medicare patients, billed 70 HCPCS/CPT codes, and received $3,052 in Medicare payments. The top billing code was 94010 (Test to measure expiratory airflow and volume). Part D data shows 380 prescription claims across 54 beneficiaries totaling $102,348 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 345 claims. Open Payments data shows 44 records totaling $986. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $197,622 to $3,052. Similarly, Part D prescription costs have fallen sharply in recent years, from $319,987 to $102,348. For DME billing, reported payments fell sharply in recent years, from $51,001 to $28,178.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	503	2,736	$197,622
2016	568	4,164	$352,577
2017	619	4,544	$377,935
2018	523	4,067	$391,659
2019	473	4,245	$431,711
2020	423	4,716	$510,731
2021	287	2,207	$312,067
2022	N/R	N/R	N/R
2023	16	70	$3,536
2024	16	70	$3,052

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	217	1,927	$319,987
2016	223	2,077	$364,956
2017	268	2,185	$372,716
2018	270	2,265	$405,036
2019	290	2,535	$513,650
2020	225	2,059	$521,297
2021	201	1,487	$437,830
2022	84	446	$195,403
2023	58	327	$143,996
2024	54	380	$102,348

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	443	1,133	$50,631
2016	549	1,468	$67,254
2017	591	1,979	$96,799
2018	680	2,168	$121,313
2019	571	1,800	$119,114
2020	519	1,645	$98,741
2021	387	1,199	$50,286
2022	268	803	$50,368
2023	185	393	$36,606
2024	137	345	$23,266

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
94010	Test to measure expiratory airflow and volume	16	28	$22

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	78	2,820	$58,774
Breo Ellipta	Fluticasone/Vilanterol	11	390	$5,080
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	450	$2,255
Albuterol Sulfate Hfa	Albuterol Sulfate	59	1,656	$1,549
Fluticasone Propionate	Fluticasone Propionate	16	600	$212

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	11	$11,232
A7030	Full face mask used with positive airway pressure device, each	N	23	44	$3,250
A7031	Face mask interface, replacement for full face mask, each	N	20	41	$2,806
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	19	42	$1,399
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	21	$1,301

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$986	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan J. Klukowicz, MD?

Tedicare shows public-source Medicare data for Alan J. Klukowicz, MD (NPI 1912959685), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan J. Klukowicz, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan J. Klukowicz, MD?

Alan J. Klukowicz, MD is linked to PULMONARY & CRITICAL CARE ASSOCIATES (billing NPI 1467536623) in the available physician profile data.

Does Alan J. Klukowicz, MD have Open Payments data?

Alan J. Klukowicz, MD has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.